Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia

1 May 1999

Abstract excerpt

We studied telomere length in the peripheral blood leukocyte samples of a large group of patients with chronic myelogenous leukemia (CML) by Southern blot hybridization using the (TTAGGG)4 probe. The average telomere length expressed as the peak telomere repeat array (TRA) of the peripheral blood samples obtained from a group of 34 healthy age-matched controls ranged between 7.6 and 10.0 kb and the mean peak TRA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesenchymal stem cell research
Share to Single-cell and spatial transcriptomics
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10331504
DOI: 10.1002/(sici)1096-8652(199905)61:1<5::aid-ajh2>3.0.co;2-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemiaPMID 10331504Read ↗

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometrySemantic proximity Read ↗

Telomere Length Dynamics in Normal Individuals and in Patients with Hematopoietic Stem Cell‐Associated DisordersSemantic proximity Read ↗

Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapySemantic proximity Read ↗

Telomere length in myelodysplastic syndromesSemantic proximity Read ↗

Telomere Shortening Correlates with Prognostic Score at Diagnosis and Proceeds Rapidly during Progression of Chronic Myeloid LeukemiaSemantic proximity Read ↗

Maintenance of telomere length in AMLSemantic proximity Read ↗

Telomeric DNA in normal and leukemic blood cells.Semantic proximity Read ↗

Telomeres and prognosis in patients with chronic lymphocytic leukaemia.Semantic proximity Read ↗

Telomere length in leukocyte subpopulations of patients with aplastic anemiaSemantic proximity Read ↗

A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells.Semantic proximity Read ↗

Allelotype analysis in the evolution of chronic myelocytic leukemia.Semantic proximity Read ↗

Progressive Telomere Shortening in Aplastic AnemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.